Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Elenagen by CureLab Oncology for Melanoma: Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Melanoma. According to GlobalData, Phase II...
Elenagen by CureLab Oncology for Ovarian Cancer: Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...
Elenagen by CureLab Oncology for Glioblastoma Multiforme (GBM): Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Glioblastoma Multiforme (GBM). According to GlobalData,...
Elenagen by CureLab Oncology for Gastric Cancer: Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
Elenagen by CureLab Oncology for Pancreatic Cancer: Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
Elenagen by CureLab Oncology for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...
Elenagen by CureLab Oncology for Uterine Cancer: Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Uterine Cancer. According to GlobalData, Phase...
Elenagen by CureLab Oncology for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Elenagen is under clinical development by CureLab Oncology and currently in Phase II for Kidney Cancer (Renal Cell Cancer). According...